SCHEMBL118665

SCHEMBL118665

CNC(=[O+]C)N(C)C.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51352 1.00
SCHEMBL4751122 1.00
SCHEMBL19665 0.89
Hydrochloric Acid SCHEMBL5860643 0.87
SCHEMBL1952432 0.85
SCHEMBL5682973 0.82
Methylene Chloride SCHEMBL2347771 0.80
SCHEMBL4962709 0.78
SCHEMBL7339903 0.78
Phosphoric Acid SCHEMBL1936779 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9346816-B2 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-24 US disclosed
US-20140066428-A1 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-06 US disclosed
US-20120165304-A1 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 US disclosed
EP-2424888-A2 INSULINOTROPIC PEPTIDE SYNTHESIS USING SOLID AND SOLUTION PHASE COMBINATION TECHNIQUES F. Hoffmann-La Roche AG (CH) 2012-03-07 EP disclosed
WO-2010125079-A2 INSULINOTROPIC PEPTIDE SYNTHESIS USING SOLID AND SOLUTION PHASE COMBINATION TECHNIQUES F. HOFFMANN-LA ROCHE AG (CH) 2010-11-04 WO disclosed
EP-2222695-A2 INSULINOTROPIC PEPTIDE SYNTHESIS USING SOLID AND SOLUTION PHASE COMBINATION TECHNIQUES F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009074483-A2 INSULINOTROPIC PEPTIDE SYNTHESIS USING SOLID AND SOLUTION PHASE COMBINATION TECHNIQUES F. HOFFMANN-LA ROCHE AG (CH) 2009-06-18 WO disclosed
EP-1363878-B1 PROCESS FOR PREPARING SULFAMOYL-SUBSTITUTED PHENETHYLAMINE DERIVATIVES YONSUNG FINE CHEMICAL CO LTD (KR) 2007-01-17 EP disclosed
EP-1363878-A4 PROCESS FOR PREPARING SULFAMOYL-SUBSTITUTED PHENETHYLAMINE DERIVATIVES YONSUNG FINE CHEMICAL CO LTD (KR) 2005-12-21 EP disclosed
EP-1363878-A1 PROCESS FOR PREPARING SULFAMOYL-SUBSTITUTED PHENETHYLAMINE DERIVATIVES Yonsung Fine Chemical Co. Ltd (KR) 2003-11-26 EP disclosed
WO-2002068382-A1 PROCESS FOR PREPARING SULFAMOYL-SUBSTITUTED PHENETHYLAMINE DERIVATIVES YONSUNG FINE CHEMICAL CO. LTD. (KR) 2002-09-06 WO disclosed